Moonlake Immunotherapeutics – Investors and Politicians Who Own It

MLTX

Investors who own it

3 tracked investors, $448.3M in shares, each from their latest 13F.

InvestorValueShare of portfolio
Mark LampertBVF Partners, Q2 2026
$311.5M7.97%
David KroinDeep Track Capital, Q2 2026
$136.3M1.98%
Daniel SchneebergerADAR1 Capital Management, Q2 2026
$525.7K0.02%

Politicians who own it

Estimated from annual disclosures and trades; values are rough estimates.

No member of Congress is estimated to hold this stock.

InvestorActionShares now
Behzad AghazadehReduced −52%2,000,000
Rod WongSold out0
Daniel SchneebergerAdded +341%151,495
Daniel SchneebergerCallNew17,000

Politicians trading it

Latest Congress trades disclosed under the STOCK Act; amounts are ranges.

No disclosed Congress trades in this stock.